3 min Read Jan 23, 2024
IPO red flags: how to spot risky new listings before they crash
2 min Read Jan 23, 2024
Cipla, the Indian pharmaceutical giant, delivered a resounding performance in its third quarter of FY2024, showcasing remarkable growth and exceeding even the most optimistic estimates....
By Shreyas Mogal
Subscribe for regular updates